Minehan K J, Bonner J A
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905.
Life Sci. 1993;53(15):PL237-42. doi: 10.1016/0024-3205(93)90544-d.
Etoposide is commonly used in combination with radiation but the best method of integrating these two treatment modalities is not known. In this study, the interaction of etoposide and radiation was investigated using V79 hamster lung fibroblast cells. It was discovered that etoposide (0.25 microgram/ml) was a dramatic radiosensitizer if it was given for a 24 hour exposure after radiation. If the cells were exposed to the same concentration of etoposide for 24 hours prior to radiation, minimal or no radiosensitization occurred. Radiosensitization correlated with a prolongation of the radiation-induced G2 cell cycle arrest. These initial studies indicate that the sequence of radiation and etoposide treatments is important in order to maximize cytotoxicity in V79 cells. Further work using human cell lines will be required to determine the clinical applications of this discovery.
依托泊苷通常与放疗联合使用,但将这两种治疗方式整合的最佳方法尚不清楚。在本研究中,使用V79仓鼠肺成纤维细胞研究了依托泊苷与放疗的相互作用。研究发现,如果在放疗后给予依托泊苷(0.25微克/毫升)24小时,它是一种显著的放射增敏剂。如果在放疗前将细胞暴露于相同浓度的依托泊苷24小时,则极少或不会发生放射增敏作用。放射增敏作用与放疗诱导的G2期细胞周期停滞的延长相关。这些初步研究表明,放疗和依托泊苷治疗的顺序对于使V79细胞的细胞毒性最大化很重要。需要使用人类细胞系进行进一步研究以确定这一发现的临床应用。